TY - JOUR
T1 - Regulating axonal responses to injury
T2 - The intersection between signaling pathways involved in axon myelination and the inhibition of axon regeneration
AU - Rao, Sudheendra N.R.
AU - Pearse, Damien D.
N1 - Publisher Copyright:
© 2016 Rao and Pearse.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/6/8
Y1 - 2016/6/8
N2 - Following spinal cord injury (SCI), a multitude of intrinsic and extrinsic factors adversely affect the gene programs that govern the expression of regeneration-associated genes (RAGs) and the production of a diversity of extracellular matrix molecules (ECM). Insufficient RAG expression in the injured neuron and the presence of inhibitory ECM at the lesion, leads to structural alterations in the axon that perturb the growth machinery, or form an extraneous barrier to axonal regeneration, respectively. Here, the role of myelin, both intact and debris, in antagonizing axon regeneration has been the focus of numerous investigations. These studies have employed antagonizing antibodies and knockout animals to examine how the growth cone of the re-growing axon responds to the presence of myelin and myelin-associated inhibitors (MAIs) within the lesion environment and caudal spinal cord. However, less attention has been placed on how the myelination of the axon after SCI, whether by endogenous glia or exogenously implanted glia, may alter axon regeneration. Here, we examine the intersection between intracellular signaling pathways in neurons and glia that are involved in axon myelination and axon growth, to provide greater insight into how interrogating this complex network of molecular interactions may lead to new therapeutics targeting SCI.
AB - Following spinal cord injury (SCI), a multitude of intrinsic and extrinsic factors adversely affect the gene programs that govern the expression of regeneration-associated genes (RAGs) and the production of a diversity of extracellular matrix molecules (ECM). Insufficient RAG expression in the injured neuron and the presence of inhibitory ECM at the lesion, leads to structural alterations in the axon that perturb the growth machinery, or form an extraneous barrier to axonal regeneration, respectively. Here, the role of myelin, both intact and debris, in antagonizing axon regeneration has been the focus of numerous investigations. These studies have employed antagonizing antibodies and knockout animals to examine how the growth cone of the re-growing axon responds to the presence of myelin and myelin-associated inhibitors (MAIs) within the lesion environment and caudal spinal cord. However, less attention has been placed on how the myelination of the axon after SCI, whether by endogenous glia or exogenously implanted glia, may alter axon regeneration. Here, we examine the intersection between intracellular signaling pathways in neurons and glia that are involved in axon myelination and axon growth, to provide greater insight into how interrogating this complex network of molecular interactions may lead to new therapeutics targeting SCI.
KW - Adaptive myelination
KW - Axon regeneration
KW - Myelination
KW - Oligodendrocytes
KW - Radial growth
KW - Schwann cell
KW - Signaling pathways
KW - Spinal cord injuries
UR - http://www.scopus.com/inward/record.url?scp=84978472632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978472632&partnerID=8YFLogxK
U2 - 10.3389/fnmol.2016.00033
DO - 10.3389/fnmol.2016.00033
M3 - Review article
AN - SCOPUS:84978472632
VL - 9
JO - Frontiers in Molecular Neuroscience
JF - Frontiers in Molecular Neuroscience
SN - 1662-5099
IS - JUNE
M1 - 33
ER -